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SUMMARY
The role of secretedmolecules in cellular reprogramminghas been poorly understood.Herewe identify a truncated formof ephrin receptor
A7 (EPHA7) as a key regulator of reprogramming. TruncatedEPHA7 isprominentlyupregulated and secretedduring reprogramming.EPHA7
expression is directly regulated byOCT3/4.EphA7knockdownresults inmarked reductionof reprogrammingefficiency, and the additionof
truncated EPHA7 is able to restore it. ERK activity ismarkedly reduced during reprogramming, and the secreted, truncated EPHA7 is respon-
sible forERKactivity reduction.Remarkably, treatmentofEphA7-knockdownMEFswith theERKpathway inhibitor restores reprogramming
efficiency. Analyses show that truncated EPHA7-induced ERK activity reduction plays an important role in themiddle phase of reprogram-
ming. Thus, our findings uncover the importance of secreted EPHA7-induced ERK activity reduction in reprogramming.
INTRODUCTION
Somatic cells can be reprogrammed to a pluripotent state
(induced pluripotent stem [iPS] cells) by defined transcrip-
tion factors (Oct3/4, Sox2,Klf4, and c-Myc, hereafter referred
to as OSKM) (Takahashi and Yamanaka, 2006). iPS cells are
almost equivalent to embryonic stem cells (ESCs) in their
properties (Okita et al., 2007; Mikkelsen et al., 2008).
Many studies have been done to elucidate the mechanism
of reprogramming (Stadtfeld et al., 2008; Samavarchi-Teh-
rani et al., 2010; Buganim et al., 2012), and several factors
that affect reprogramming efficiency have also been re-
vealed (Huangfu et al., 2008; Onder et al., 2012; Costa
et al., 2013). But the importance of cell-cell interactions
and secreted, extracellular molecules in reprogramming
has not been extensively studied.
To approach this problem, we focused on EPHRIN re-
ceptor (EPH)/EPHRIN (EFN) signaling pathways. EPH re-
ceptors and EPHRINs are both anchored to the plasma
membrane and form an important cell communication
system with roles in normal physiology and disease path-
ogenesis (Pasquale, 2010). The EPH/EPHRIN signals prop-
agate bidirectionally into both the EPH-expressing cells
(forward signaling) and the EPHRIN-expressing cells
(reverse signaling) to elicit different effects on each cell
(Pasquale, 2008). Several EPH receptors and EPHRINs
have truncated forms, which are secreted and function
to propagate or repress signals (Aasheim et al., 2000;
Dawson et al., 2007; Wykosky et al., 2008). Recently,
some of EPH receptors and EPHRINs have been identified
as regulators of stem and progenitor cell proliferation
(Holmberg et al., 2005, 2006; Jiao et al., 2008; Nomura
et al., 2010). However, whether EPH/EPHRIN signaling
pathways regulate cell reprogramming has been
unknown.
In this study, we found that EPHA7, among EPH and EFN
members, is most prominently upregulated during reprog-
ramming and that secreted, truncated EPHA7 plays a
crucial role in reprogramming through inducing ERK activ-
ity reduction.
RESULTS
EPHA7 Is Prominently Upregulated during Mouse
Embryonic Fibroblast Reprogramming
We measured the changes in the expression levels of Eph-
and Efn-family genes during OSKM-induced reprogram-
ming of mouse embryonic fibroblasts (MEFs) and found
that EphA7 shows the most prominent upregulation. The
upregulation of EphA7 preceded the induction of E-cad-
herin and the pluripotency markers Nanog and Oct3/4 (Fig-
ures 1A, 1B, S1A, and S1B). Because there exists a secreted,
truncated form of EPHA7 (truncated EPHA7), which is a
splice variant and lacks kinase activity (Dawson et al.,
2007; Oricchio et al., 2011), we examined truncated
EphA7. Truncated EphA7 was markedly upregulated from
early periods of reprogramming (Figure 1A). But the expres-
sion levels of EphA7 and truncated EphA7were low in estab-
lished iPS cells and ESCs (Figure 1A).








Figure 1. EPHA7 Is Upregulated during MEF Reprogramming
(A) qRT-PCR analysis of EphA7 (full-length plus truncated EphA7) and truncated EphA7. Ctrl (control), mCherry instead of OSKM.
(B) qRT-PCR analysis of Nanog, endogenous Oct3/4, and E-cadherin.
(legend continued on next page)
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The protein level of full-length EPHA7 was increased
markedly at day 4 and then gradually decreased, and trun-
cated EPHA7 protein was markedly increased at day 6 (Fig-
ure 1C). Analyses of the conditioned medium indicated
that truncated EPHA7 protein was secreted during reprog-
ramming (Figures 1D and 1E).
We next examined which factor is responsible for the up-
regulation of EphA7. Ectopic expression of Oct3/4 alone,
but not Sox2, Klf4, or c-Myc, in MEFs resulted in marked in-
creases in the expression levels of both full-length EphA7
and truncated EphA7 (Figure 1F), indicating that OCT3/4
plays a major role in the induction of EphA7. The analysis
showed that OCT3/4 strongly upregulated the expression
of both full-length and truncated EphA7 within 24 hr (Fig-
ure 1G). Chromatin immunoprecipitation assays showed
that OCT3/4 directly bound to at least one site among
five potential OCT3/4-binding sites (Figure 1H) (Nishimoto
et al., 2003) in the upstream region of EphA7 (Figure 1I),
suggesting that OCT3/4 directly regulates the expression
of EphA7. OCT3/4weakly bound to the EphA7 promoter re-
gion in ESCs (Figure S1C), consistent with the low expres-
sion of EphA7 in ESCs.
Truncated EPHA7 Plays a Crucial Role in
Reprogramming
We then examined the effect of EphA7 knockdown on the
reprogramming efficiency. EphA7mRNA levels were mark-
edly reduced by each EphA7 small hairpin RNA (shRNA)
(Figure 2A). The protein levels of both full-length and trun-
cated EPHA7 and the amounts of secreted, truncated
EPHA7 protein were markedly reduced by each EphA7
shRNA (Figure S2A). EphA7 knockdown resulted in marked
reduction in the mRNA and protein levels of NANOG (Fig-
ures 2B and S2A) and the numbers of alkaline phosphatase–
positive colonies and NANOG-positive colonies (Figures
2C and S2B). The efficiency of OSK-mediated reprogram-
ming was also markedly reduced by EphA7 knockdown
(Figure S2C). These results show that EPHA7 promotes
reprogramming.
We examined whether introduction of EPHA7 could
reverse the decreased reprogramming efficiency of EphA7-
knockdown cells. When full-length EPHA7 was introduced
to EphA7-knockdown cells, the reprogramming efficiency
was not improved (Figures 2D, 2F, and S2D). In contrast,
the addition of EPHA7FC, which is a truncated form of
EPHA7 protein, to the culture mediummarkedly increased
reprogramming efficiency (Figures 2E, 2F, S2E, and S2F).
These results indicate that secreted, truncated EPHA7, but
not full-length EPHA7, contributes to promoting cell re-
programming. The addition of EPHA7FC enhanced the re-
programming efficiency of control MEFs (Figures 2E and
2F). We then examined whether truncated EPHA7 acts on
specific phases of reprogramming or all the way along re-
programming. Data showed that the number of NANOG-
positive colonies was significantly increased when
EPHA7FC was added after day 6 (Figure 2G), suggesting
that truncated EPHA7 has a stronger effect on the middle
and/or late phases than on the early phase.
Knockdown of EfnA3, which shows the most prominent
upregulation during reprogramming among Ephrin genes,
did not significantly affect reprogramming efficiency (Fig-
ure S2G). This result, together with the above finding
that truncated EPHA7, which is shown to function to
inhibit EPH signaling (Dawson et al., 2007; Oricchio
et al., 2011), but not full-length EPHA7, plays a positive
role in reprogramming, suggests that inhibition of EPH
signaling is important for reprogramming. Because there
are many other ligands for EPHA7, knockdown of EfnA3
may not produce a large effect.
Truncated EPHA7 Promotes Cell Reprogramming by
Inducing ERK Activity Reduction
It has previously been shown that secreted, truncated
EPHA7 inhibits EPH signaling, which induces the phos-
phorylation and activation of ERK1/2 in lymphomas (Oric-
chio et al., 2011), and that the levels of phosphorylated
ERK1/2 (pERK1/2) are increasedwhenmouse ESCs lose plu-
ripotency and start to differentiate (Kim et al., 2012). We
thus reasoned that truncated EPHA7 would regulate
cellular reprogramming by controlling ERK1/2 activity.
We then examined pERK1/2 levels during reprogramming
and found that pERK1/2 levels weremarkedly reduced after
(C) Immunoblotting analysis for EPHA7, NANOG, E-CADHERIN, and a-TUBULIN (as a loading control). Triangles indicate full-length EPHA7
(top) and truncated EPHA7 (bottom).
(D) Immunoblotting analysis of conditioned media. A triangle indicates truncated EPHA7.
(E) ELISA of the conditioned medium for EPHA7.
(F) qRT-PCR analysis of EphA7 and truncated EphA7. mCherry (Ctrl), Oct3/4, Sox2, Klf4, c-Myc, or OSKM was introduced to MEFs at day 0.
(G) qRT-PCR analysis of both full-length EphA7 and truncated EphA7. Oct3/4 was introduced to MEFs at time 0. Ctrl, mCherry.
(H) Potential OCT3/4 biding sites in the upstream region of EphA7.
(I) Chromatin fragments of the OCT3/4 introduced MEFs were immunoprecipitated with control immunoglobulin G (IgG) or anti-OCT3/4
antibody. Each site was quantified by qRT-PCR. The values with control IgG were set to 1. Data are shown as mean ± SEM (sites B and D,
n = 4 [*p < 0.05]; site E, n = 3; site A, n = 2 independent experiments; site C, not detected). The p values were calculated using Student’s
unpaired two-tailed t tests.
In (A), (B), (F), and (G), data are shown as mean ± SEM (n = 3 independent experiments).






Figure 2. Truncated EPHA7 (EPHA7FC), but Not Full-Length EPHA7, Enhances Reprogramming Efficiency
(A) Knockdown efficiencies of EphA7 shRNAs. EphA7 mRNA levels at day 6 were determined. Luciferase shRNA (sh Luc), control.
(B) Effect of EphA7 shRNAs on Nanog mRNA levels during reprogramming.
(legend continued on next page)
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day 6 of reprogramming in parallel with EPHA7 upregula-
tion (Figure 3A, OSKM; Figures 1A–1E).
The analysis revealed that the reduction of pERK1/2
levels during reprogramming was suppressed in EphA7-
knockdown cells (Figure 3B). pERK1/2 levels were reduced
to the lowest level at day 6, when the induction of
E-CADHERIN began to occur (Figure 3B). Remarkably,
the addition of EPHA7FC to the culture medium reversed
the EphA7 knockdown-induced suppression of pERK1/2
reduction and thus caused pERK1/2 reduction again
(Figure 3C).
Because ERK1/2 activity reduction is likely to play a role
in promoting cellular reprogramming, we examined
whether treatment with the specific inhibitor of MEK, an
activator of ERK1/2, gives the same effect as the addition
of truncated EPHA7 on reprogramming. The results
showed that incubation of EphA7-knockdown cells with
the MEK inhibitor PD0325901 during the reprogramming
process significantly restored reprogramming efficiency
(Figures 3D and S3A). Moreover, PD0325901 treatment
enhanced the reprogramming efficiency of control MEFs
(Figure S3B). These effects were the same as those of the
addition of truncated EPHA7 (see Figure 2E). Furthermore,
EPHA7FC and MEK inhibition did not have additive effects
on reprogramming efficiency (Figure 3E). These results sup-
port our idea that truncated EPHA7 promotes cellular re-
programming by inducing ERK1/2 activity reduction.
Inhibition of MEK is shown to be helpful to ESC estab-
lishment and maintenance (Ying et al., 2008; Shi et al.,
2008; Silva et al., 2009). To examine whether truncated
EPHA7 has an effect on pluripotency maintenance, ESCs
were treated with EPHA7FC, and mRNA levels of pluripo-
tency markers, such as Nanog and Klf2, were examined.
Data showed that EPHA7FC did not increase the expression
of pluripotency marker genes, while treatment with
PD0325901 or 2i (PD0325901 and CHIR99021; GSK-3b in-
hibitor) significantly increased their expression (Fig-
ure S3C). Furthermore, EPHA7FC treatment did not reduce
pERK1/2 levels in ESCs (Figure S3D). Thus, the regulation
of ERK1/2 activity by truncated EPHA7 may not be
involved in pluripotency maintenance in ESCs.
Pre-reprogrammedCells Secrete Truncated EPHA7 and
Support SSEA-1 Negative Cells to Progress toward a
Pluripotent State
We examined pERK1/2 levels of cells, which were sorted by
the expression intensity of SSEA-1, an early pluripotency
marker, or that of NANOG (Figure S4A). The analysis re-
vealed that pERK1/2 levels were reduced to a greater extent
in SSEA-1- and NANOG-positive cells than in SSEA-1- and
Nanog-negative cells, respectively (Figure 4A), suggesting
that the progress of reprogramming is accompanied by
the reduction of pERK1/2 levels.
We then found that both full-length EphA7 and trun-
cated EphA7 were expressed to a much higher extent in
NANOG-negative cells than in NANOG-positive cells at
the late time point (day 12) of reprogramming (Figure 4B).
Moreover, we performed puromycin selection experiments
by using MEFs derived from Nanog-GFP-IRES-PuroR mice
(Okita et al., 2007), which express GFP and the puromy-
cin-resistant gene under the control of theNanog promoter
(Figure 4C). We treated the cells with puromycin from day
7 to day 9 after OSKM introduction. Data also showed that
both full-length EphA7 and truncated EphA7 were ex-
pressed to a much higher extent in NANOG-negative
(puro) cells than in NANOG-positive (puro+) cells (Fig-
ure 4D) and that the amount of secreted, truncated
EPHA7 in the culture medium was greater in non-puromy-
cin-added cell cultures than in puromycin-added ones (Fig-
ure 4E). These results suggest that EPHA7 expression was
markedly decreased in fully reprogrammed cells.
We asked whether pre-reprogrammed cells expressing
truncate EPHA7 are able to support other cells to progress
toward a pluripotent state, and which kind of cells were
affected by truncated EPHA7. We sorted OSKM-introduced
Nanog-GFP MEFs into SSEA-1-positive and SSEA-1-negative
cells at days 8 and 12. Sorted cells were then plated on the
control shRNA-treated, OSKM-introduced wild-type (WT)
MEFs or EphA7 shRNA-treated, OSKM-introduced WT
MEFs, and the number of Nanog-GFP colonies was exam-
ined. The results showed that the number of Nanog-GFP
positive colonies was reduced when sorted cells were
cultured on the EphA7-knockdown feeder cells at both
(C) Effect of EphA7 shRNAs on the number of NANOG-positive colonies. Left: representative images at day 12 (left). Top: NANOG-positive
colonies; bottom: Hoechst. The scale bars represent 2 mm. Right: quantification.
(D) Effect of exogenous expression of full-length EPHA7 on reprogramming efficiency. Full-length EphA7 ormCherry (Ctrl) was expressed in
control shRNA-treated, OSKM-introduced MEFs (sh Luc) or in EphA7 shRNA-treated, OSKM-introduced MEFs (sh EphA7 #1 and #4). In (D),
(E), and (G), quantification of the NANOG-positive colonies is shown.
(E) Effect of the addition of truncated EPHA7 protein to the culture medium on reprogramming efficiency. EPHA7FC (a truncated form of
EPHA7; 5 mg/ml) was added to the culture medium at day 6 and incubated until day 10.
(F) Effect of the exogenous expression of full-length EphA7 or the addition of truncated EPHA7 protein to the culture medium on Nanog
mRNA levels during reprogramming.
(G) Effect of the addition of truncated EPHA7 protein (EPHA7FC) to the culture medium at the different time points.
In (A)–(G), data are shown as mean ± SEM (n = 3 independent experiments; n = 4 independent experiments in [C]; *p < 0.05, **p < 0.01,
***p < 0.001). The p values were calculated using Student’s unpaired two-tailed t tests.
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Figure 3. Truncated EPHA7 Promotes MEF Reprogramming through Inducing ERK Activity Reduction
(A) Immunoblotting analysis for pERK1/2 in mCherry (Ctrl) or OSKM-introduced MEFs. The samples here were the same as those used in
Figure 1C.
(B) Immunoblotting analysis for pERK1/2 levels in EphA7 shRNA-treated cells.
(legend continued on next page)
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days 8 and 12 (Figures 4F and S4B). The extent of the reduc-
tion of Nanog-GFP positive colonies by EphA7 knockdown
in feeder cells was larger in SSEA-1-negative cells than in
SSEA-1-positive cells at day 8. Next, SSEA-1-positive and
SSEA-1-negative cells from OSKM-introduced Nanog-GFP
MEFs were sorted at day 8 and plated on MEF feeder cells,
and PBS or EPHA7FC was added to the culture medium.
We also prepared OCT3/4-overexpressing MEFs as feeder
cells as OCT3/4 is responsible for the upregulation of trun-
cated EphA7. The results showed that treatment with trun-
cated EPHA7 or the use of OCT3/4-overexpressing feeder
cells enhanced the generation of Nanog-positive colonies,
especially from SSEA-1 negative cells (Figure 4G). Taken
together, our results suggest that truncated EPHA7 is ex-
pressed and secreted frompre-reprogrammed cells and sup-
ports SSEA-1-negative cells to progress toward a pluripotent
state.
DISCUSSION
Here, we have demonstrated that EPHA7 is upregulated
during the early and middle periods of MEF reprogram-
ming and that secreted, truncated EPHA7 promotesMEF re-
programming through inducing ERK1/2 activity reduction.
EPH receptors and EPHRINs are critical regulators of cell-
cell interactions and known to transmit bidirectional
signaling. Moreover, several of EPH receptors and EPHRINs
have their truncated forms, which are secreted to regulate
EPH/EPHRIN signaling. Our results demonstrate that a
truncated form of EPHA7, but not full-length EPHA7, plays
a crucial role in reprogramming and that truncated EPHA7
is secreted to the culture medium to influence surrounding
cells and promote their reprogramming.
Previous studies have demonstrated that the inhibition
of ERK1/2 activity plays a role in acquiring and maintain-
ing the naive pluripotent state of ESCs and iPS cells (Silva
et al., 2008; Ying et al., 2008). However, neither ERK1/2 ac-
tivity changes during reprogramming nor their role in re-
programming has been addressed. Our data show that the
reduction of ERK1/2 activity by truncated EPHA7 occurs
in the middle phase (around day 6) of reprogramming
and is essential for driving reprogramming.
Our results show that pre-reprogrammed cells mainly ex-
press and secrete truncated EPHA7 and that truncated
EPHA7 has a stronger effect on SSEA-1-negative cells than
on SSEA-1-positive cells. Notably, the reduction of the
pERK/1/2 levels began at day 6 of reprogramming, SSEA-
1-positive cells also started to emerge at day 6, and
pERK1/2 levels remained higher in SSEA-1-negative cells
than in SSEA-1-positive cells at day 6. Collectively, our re-
sults suggest that EPHA7-induced ERK activity reduction
has a stronger effect on the middle phase of reprogram-
ming and supports SSEA-1-negative cells to progress toward
a pluripotent state.
The expression of truncated EPHA7 during reprogram-
ming is transient, unlike most of the reprogramming-
related genes that have high expression levels in mature
ESCs or iPS cells. Microarray data in earlier reports (Mikkel-
sen et al., 2008; Sridharan et al., 2009; Samavarchi-Tehrani
et al., 2010) also indicated that EPHA7 was mainly ex-
pressed in reprograming cells but not in ESCs or iPS cells.
Moreover, our results show that the regulation of ERK1/2
activity by truncated EPHA7 is specific to cell reprogram-
ming and may not be involved in pluripotency mainte-
nance in ESCs and that the expression of eph receptors
and ephrins is quite low in ESCs and iPS cells, indicating
that EPH-EPHRIN signaling might not be involved in the
regulation of the ERK1/2 pathway in ESCs.
Our analysis has demonstrated that the ERK activity
reduction is not a result of the completion of reprogram-
ming but is a crucial event during reprogramming, which
drives reprogramming. This study identifies a secreted fac-
tor responsible for the ERK1/2 activity reduction during re-
programming. Thus, our findings reveal the importance of
cell-cell communications during reprogramming.
EXPERIMENTAL PROCEDURES
Cell Culture Protocols
The MEFs for microarray, qRT-PCR analyses (experiments for Fig-
ures 1A, S1A, and S1B) and establishment of iPS cells (Figure S2F)
were from E13.5 ICR mice. In other experiments, MEFs were
derived bymating ICRmice andNanog-GFP-IRES-PuroRmice (pro-
vided by RIKEN BRC through the national Bio-Resource Project of
(C) Effect of the addition of truncated EPHA7 on pERK1/2 levels. EPHA7FC (5 mg/ml) was added to the culture medium in OSKM-introduced
MEFs treated with EphA7 shRNA #4 or sh Luc at day 8.
(D) EphA7 shRNA (#1)-treated, OSKM-introduced MEFs were treated with the MEK inhibitor PD0325901 (0.5 mM) for 2 days as indicated and
examined for the number of Nanog-positive colonies at day 12. Left: representative images; right: quantification. The scale bars represent
1 mm.
(E) Effect of the addition of truncated EPHA7 and/or the MEK inhibitor (PD0325901) treatment on reprogramming efficiency. EPHA7FC was
added to the culture medium from day 6 to day 10. PD0325901 treatment was from day 7 to day 8. The number of NANOG-positive colonies
at day 12 was examined.
In (D) and (E), data are shown as mean ± SEM (n = 3 independent experiments; *p < 0.05, **p < 0.01, ***p < 0.001). The p values were
calculated using Student’s unpaired two-tailed t tests.







Figure 4. Truncated EPHA7 Is Expressed and Secreted from Pre-reprogramming Cells and Supports SSEA-1-Negative Cells to
Progress toward a Pluripotent State
(A) Immunoblotting analysis for pERK1/2 levels of the sorted samples (shown in Figure S4A).
(B) qRT-PCR analysis of truncated EphA7 in the sorted samples.
(legend continued on next page)
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MEXT) (Okita et al., 2007). The MEFs were maintained in DMEM)
containing 10% fetal bovine serum (FBS). The Plat-E cells were
maintained in DMEM containing 10% FBS, puromycin (1 mg/ml),
and blasticidin S (10 mg/ml). HEK293T cells were maintained in
DMEM containing 10% FBS and kanamycin (250 mg/ml). Cells un-
dergoing reprogramming and ESCs (HT7) were cultured in a stan-
dard mouse ES medium containing 7.5% knockout serum replace-
ment (Invitrogen), 7.5% HyClone standard FBS (Thermo) and
1,000 U/ml leukemia inhibitory factor (LIF) (Millipore). ESCs and
mature iPS cells (iPS-MEF-Ng-20D-17; provided by the RIKEN BRC
through the Project for Realization of Regenerative Medicine and
the National Bio-Resource Project of MEXT) were cultured and
passed on the mitomycin-C-treated MEF feeder cells in mouse ES
medium with 1,500 U/ml LIF. All mouse experiments were
conducted in accordance with the Regulation on Animal Experi-
mentation at Kyoto University and approved by the Animal Exper-
imentation Committee of Kyoto University.
Generation of Mouse iPS Cells
In each gelatin-coated 35mmdish, 13 105MEFs were seeded. The
next day, cells were infected with the retroviruses in DMEM con-
taining 10% FBS (day 0). Sixteen hours after infection, themedium
was replaced with mouse ES medium. On day 2, the cells were
plated onto new gelatin-coated 35 mm dishes, and ES medium
was changed every 2 days. For the knockdown experiments,
MEFs were infected with lentiviruses 2 days before infection with
the retroviruses. For the rescue experiments, we added mouse re-
combinant EPHA7-Fc (EPHA7FC, R&D Systems, 608-A7-200) or
PD0325901 (WAKO, 163-24001). EPHA7-Fc protein has the extra-
cellular domain of mouse EPHA7 (Ala30-Pro549) and thus acts as
truncated, secreted EPHA7.
SUPPLEMENTAL INFORMATION
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